Your browser doesn't support javascript.
loading
A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting Melanoma.
Shi, Jing; Jiao, Tao; Guo, Qian; Weng, Weining; Ma, Linjie; Zhang, Qing; Wang, Lijun; Zhang, Jianjian; Chen, Caiwei; Huang, Yaling; Wang, Mingqiao; Pan, Rong; Tang, Yanfang; Hu, Wenhao; Meng, Tao; Liu, Shu-Hui; Guo, Jun; Kong, Yan; Meng, Xun.
Afiliação
  • Shi J; Multitude Therapeutics, Shanghai, China.
  • Jiao T; Department of Renal Cancer and Melanoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Guo Q; Department of Renal Cancer and Melanoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Weng W; Multitude Therapeutics, Shanghai, China.
  • Ma L; Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Zhang Q; Multitude Therapeutics, Shanghai, China.
  • Wang L; Multitude Therapeutics, Shanghai, China.
  • Zhang J; Multitude Therapeutics, Shanghai, China.
  • Chen C; Multitude Therapeutics, Shanghai, China.
  • Huang Y; Multitude Therapeutics, Shanghai, China.
  • Wang M; Multitude Therapeutics, Shanghai, China.
  • Pan R; Abmart, Shanghai, China.
  • Tang Y; Abmart, Shanghai, China.
  • Hu W; Multitude Therapeutics, Shanghai, China.
  • Meng T; Abmart, Shanghai, China.
  • Liu SH; Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Guo J; MabCare Therapeutics, Shanghai, China.
  • Kong Y; HySlink Therapeutics, Shanghai, China.
  • Meng X; Multitude Therapeutics, Shanghai, China.
Cancer Res ; 83(22): 3783-3795, 2023 11 15.
Article em En | MEDLINE | ID: mdl-37668527

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Canais de Cátion TRPM / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Canais de Cátion TRPM / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article